Cabaletta Bio, Inc. (CABA)
2.91
-0.36
(-11.01%)
USD |
NASDAQ |
Sep 09, 16:00
2.96
+0.05
(+1.72%)
After-Hours: 06:37
Cabaletta Bio EPS Diluted (Quarterly) : -0.3375 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3375 |
| March 31, 2026 | -0.3884 |
| December 31, 2025 | -0.4172 |
| September 30, 2025 | -0.4387 |
| June 30, 2025 | -0.7293 |
| March 31, 2025 | -0.7083 |
| December 31, 2024 | -0.65 |
| September 30, 2024 | -0.6191 |
| June 30, 2024 | -0.5582 |
| March 31, 2024 | -0.508 |
| December 31, 2023 | -0.47 |
| September 30, 2023 | -0.3741 |
| June 30, 2023 | -0.3698 |
| March 31, 2023 | -0.4472 |
| December 31, 2022 | -0.5329 |
| Date | Value |
|---|---|
| September 30, 2022 | -0.3938 |
| June 30, 2022 | -0.4454 |
| March 31, 2022 | -0.4471 |
| December 31, 2021 | -0.49 |
| September 30, 2021 | -0.4472 |
| June 30, 2021 | -0.4504 |
| March 31, 2021 | -0.4083 |
| December 31, 2020 | -0.3869 |
| September 30, 2020 | -0.3489 |
| June 30, 2020 | -0.3392 |
| March 31, 2020 | -0.3114 |
| December 31, 2019 | -0.2248 |
| September 30, 2019 | -0.1935 |
| December 31, 2018 | -0.0793 |
| September 30, 2018 | -0.386 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 4.366 |
| Anika Therapeutics, Inc. | 0.2412 |
| BioCryst Pharmaceuticals, Inc. | 0.2957 |
| Imunon, Inc. | -0.5412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -51.02M |
| Total Expenses (Quarterly) | 51.02M |
| Enterprise Value | 288.70M |
| Earnings Yield | -54.36% |
| Normalized Earnings Yield | -54.36 |